Artículos

Publicado el 20 de julio de 2009

Reunión de expertos en México

Conferencias Influenza A (H1/N1)

Acceso a las ponencias de destacados especialistas presentadas en la reunión realizada en el mes de Julio en México.










Acceda a las conferencias en idioma inglés y en formato PDF


1. Vigilancia:

• Natural History of Disease and Biological Aspects of Influenza A
(H1N1)


• Influenza A (H1/N1) Pandemic
Dr. Timothy M. Uyeki, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC

Vigilancia en diferentes ámbitos

• Human Surveillance
Prof. Nigel Lightfoot, C.B.E. Chief Advisor, Emergency Preparedness and Head of Influenza Programme Health Protection Agency

• Animal Surveillance
Dr. Brian Evans. Executive Vice-President, Canadian Food Inspection Agency



2. Medidas en fronteras y aeropuertos

• Screening Travelers at Borders During a Pandemic: Some Thoughts About Tools
Dr. Peter Houck. Division of Global Migration & Quarantine (DGMQ), CDC



3. Vigilancia en sitios turísticos


• Disease Surveillance in Tourists
Dr. Gary Brunette. Division of Global Migration & Quarantine (DGMQ), CDC



4. Espectro clínico de la enfermedad

• Spectrum of desease influenza A H1N1
Dr. Rogelio Pérez Padilla. General Director of the National Institute of the National Institute of Respiratory Diseases, Mexico

• Clinical Issues - Pandemic Influenza A (H1N1) Virus Infection
Dr. Timothy M. Uyeki. Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC

• Influenza A H1N1 New York City and MSKCC EXPERIENCE
Dr. Carlos M. Jaramillo Hoyos. Infectious Diseases Department, Memorial Sloan-Kettering Cancer Center, US

• Clinical spectrum of disease, Mortality related to influenza A (H1 N1) in Mexico
Dr. Germán Fajardo Dolci. CONAMED, Mexico




5. Capacidad y respuesta hospitalaria

• Capacidad y respuesta hospitalaria
Dr. Alejandro Macías. Infectologist. National Institute of Health Sciences and Nutrition, Salvador Zubirán, Mexico



6. Tratamiento y profilaxis

• Antiviral Treatment and Chemoprophylaxis of Pandemic Influenza A (H1N1) Virus
Dr. Timothy M. Uyeki, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC

• U.S. Strategic National Stockpile: Strategies for Influenza Mitigation
Mr. Steven Adams. Deputy Director, Division of National Strategic Stockpile (DSNS), CDC




7. Medidas de Salud Pública

• Pandemic Novel H1N1 Influenza Surveillance, United States
Dr. Nancy Cox, Director of Influenza Division, CDC



8. Vaccines


• Influenza Vaccines
Dr. Nancy Cox, Director of Influenza Division, CDC

• 2009 Pandemic Public Health Measures: Vaccine, Comprehensive Family Immunization Project Family and Community Health
Dr. Jon Kim Andrus, Lead Technical Advisor for the Immunization Unit  of the Pan American Health Organization, PAHO


9. Planes operativos: del plan a la acción

• Vaccines. Operationalization of Pandemic Plans – from Plan to Action
Dr. Walter Orenstein. Deputy Director Vaccine-Preventable Diseases.


• Externalidades
Dr. Rogelio Granguillhome. Chief of International Cooperation and Economic Relations Unit. Ministry for Foreign Affairs, Mexico